MAXHEALTH vs MEDANTA: Stock Comparison
MAX HEALTHCARE INS is the larger company by market capitalisation. MAX HEALTHCARE INS shows a lower P/E, a higher dividend yield and a higher ROCE, while GLOBAL HEALTH shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
MAXHEALTH leads 6; MEDANTA leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | MAXHEALTH | MEDANTA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | MAXHEALTH | MEDANTA |
|---|---|---|
| Live Price | ₹853.35 | ₹1,297.6 |
| Day Change | 0.26% | -0.16% |
| Volume | 2.21 L | 4,243 |
| 52-Week High | ₹1,189 | ₹1,544 |
| 52-Week Low | ₹797 | ₹956 |
| Distance from 52W High | -28.23% | -15.96% |
Valuation
| Metric | MAXHEALTH | MEDANTA |
|---|---|---|
| Market Cap | ₹83,096 Cr | ₹34,818 Cr |
| P/E Ratio | 56.84x | 62.54x |
| P/B Ratio | 7.71x | 8.78x |
| EPS | ₹3.32 | ₹5.9 |
| Book Value | ₹110.42 | ₹148.18 |
| Dividend Yield | 0.23% | 0.04% |
Growth
| Metric | MAXHEALTH | MEDANTA |
|---|---|---|
| Revenue Growth (TTM YoY) | 12.2% | 24.5% |
| EPS Growth (TTM YoY) | 7.3% | 42% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | MAXHEALTH | MEDANTA |
|---|---|---|
| ROE | 13.42% | 13.91% |
| ROCE | 12.13% | 11.9% |
| Net Margin | 17.23% | 12.62% |
| Operating Margin | 22.82% | 18.01% |
| Debt to Equity | 0.32x | 0.3x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | MAXHEALTH | MEDANTA |
|---|---|---|
| Promoter Holding | 23.71% | 33% |
| FII Holding | 40.52%▼ 1.26 pp | 9.91%▲ 0.45 pp |
| DII Holding | 31%▲ 1.04 pp | 17.01%▲ 0.12 pp |
| Public Holding | 4.76%▲ 0.2 pp | 39.97%▼ 0.59 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MAX HEALTHCARE INS and GLOBAL HEALTH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.